BioCryst Pharma Reports Positive Results From Mid-Stage Study Of Arthritis ... - Daily Markets

HealthNewsDigest.com

BioCryst Pharma Reports Positive Results From Mid-Stage Study Of Arthritis ... Daily Markets According to Biocryst, it is the only PNP inhibitor in development for gout. Gout is an inflammatory arthritis that affects up to five million people in the ... How To Avoid A Bout Of GoutNorth American Press Syndicate BioCryst Reports Positive Results from Part One of Its Phase 2a Study of ...MarketWatch (press release) Wednesday Winners: Semis Continue Their AscentStreetAuthority all 40 news articles »

What to Do if You Have Arthritis, Part One - Huffington Post (blog)

What to Do if You Have Arthritis, Part One Huffington Post (blog) ... does not process normal constituents properly (such as gout and pseudo gout), hereditary factors and infections. Arthritis can be caused by tick bites, ... Seminar will focus on arthritisVentura County Star Woman's Doc: Treating Rheumatoid ArthritisWBAL Baltimore Chronic Joint Pain With ArthritisOfficialWire (press release) all 5 news articles »

Pics show me I'll be dead at 40 if I carry on overeating - The Sun

Pics show me I'll be dead at 40 if I carry on overeating The Sun She may have had joint replacements and developed gout, meaning her mobility is severely restricted. Her weight will affect her fertility, so she may have ... and more »

Robert Langreth is a senior editor at Forbes, in charge of health care coverage - Forbes (blog)

Forbes (blog)

Robert Langreth is a senior editor at Forbes, in charge of health care coverage Forbes (blog) ... a new biotech gout treatment now in final-stage trials, and a immune-system targeting drug called AIN457 that is in testing for rheumatoid arthritis, ... and more »